News Daily News SCAD Readmissions Common After Acute MI, Especially in Young Women L.A. McKeown April 20, 2020
News As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI Michael O'Riordan April 17, 2020
News Daily News Structural Heart Interventions in the Midst of COVID-19: Today’s Advice, Tomorrow’s Unknowns Shelley Wood April 13, 2020
News Features ‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19 Michael O'Riordan April 07, 2020
News Conference News ACC 2020 Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT Todd Neale April 02, 2020
News Conference News ACC 2020 Ischemia Burden Not Linked to Angina in Nonobstructive CAD: CIAO Michael O'Riordan March 31, 2020
News Conference News ACC 2020 ISCHEMIA in Print: New MI Data and More Calls for Longer Follow-up Shelley Wood March 30, 2020
News Conference News ACC 2020 VOYAGER PAD: Rivaroxaban Bests Aspirin Alone for Preventing Limb and CV Events L.A. McKeown March 28, 2020
News Conference News ACC 2020 Diabetes May Boost Benefits of COMPASS Dual Antithrombotic Approach Todd Neale March 28, 2020
News Conference News ACC 2020 Colchicine Cost-effective in Canada, and Even in the US: COLCOT Caitlin E. Cox March 28, 2020
News Conference News ACC 2020 More Symptoms, Less Extensive Disease in Women With Stable CAD: ISCHEMIA Michael O'Riordan March 28, 2020
News Daily News ACE Inhibitors, ARBs, and COVID-19: New Insights, Advice Yael L. Maxwell March 26, 2020
News Conference News ACC 2020 Low Mortality Rates Seen With Andexanet Alfa for Factor Xa-Related Bleeds Todd Neale March 25, 2020
News Conference News ACC 2020 Statins May Have Protective Effect on Chemotherapy-Induced Cardiotoxicity Yael L. Maxwell March 19, 2020
News Daily News Potent Antithrombotic Therapy Cuts Spontaneous MI After PCI for ACS Yael L. Maxwell March 10, 2020
News Daily News Choosing a DOAC? Apixaban May Have an Edge Over Rivaroxaban Todd Neale March 09, 2020